Medication Guide for Japanese Chloraniline Carbamate Tablets

Japanese chloroaniline carbamate tablets are a central skeletal muscle relaxant, mainly used to treat painful spasms caused by motor system disorders. The drug is developed and produced by Japan's Sawei Pharmaceuticals. Its specifications include 125mg and 250mg tablets. It must be used strictly in accordance with doctor's instructions. The article will cover three aspects: medication guide, contraindications and medication for special groups to help readers fully understand the correct use and precautions of this drug.

Medication Guide for Chloraniline Carbamate Tablets

Patients should use Chloraniline Carbamate Tablets correctly under the guidance of a doctor. The following content will introduce in detail the usage, dosage, adverse reactions and storage methods of the drug.

Usage and Dosage

The usual dosage for adults is 250 mg once, 3 times a day, orally after meals. Take 2 tablets of 125 mg at a time, and the dosage can be adjusted appropriately according to the patient's gender, age, and severity of symptoms. During medication, you need to avoid driving or operating dangerous machinery to prevent accidents caused by drowsiness or decreased concentration.

Adverse reactions

This drug may cause major side effects such as bone marrow suppression and toxic epidermal necrolysis. Common adverse reactions include drowsiness, headache, indigestion, rash, etc. If severe discomfort occurs, discontinue medication immediately and seek medical advice.

Storage method

The drug needs to be stored in a dark and dry place at room temperature and is valid for 36 months. Medicines packaged in PTP should be taken out of the aluminum-plastic plate to prevent esophageal damage caused by accidentally swallowing the aluminum-plastic plate.

Following medication guidelines can help improve treatment effectiveness while reducing the risk of adverse reactions.

Contraindications of Japanese Chloroaniline Carbamate Tablets

The following content will list the contraindications and precautions for this drug.

Contraindicated in patients with liver dysfunction

This drug is strictly prohibited in patients with severe liver dysfunction. People with a history of abnormal liver function need to use medication with caution under the guidance of a doctor and monitor liver function regularly.

Contraindicated for patients with a history of allergies

Contraindicated for patients allergic to chloroaniline carbamate or other components of the drug. Before taking medication, you should inform your doctor in detail about your allergic history to avoid causing allergic reactions.

Drug interactions

When combined with central nervous system depressants (such as barbiturates, benzodiazepines), the sedative effect may be enhanced. CYP3A metabolizing enzyme inhibitors may lead to increased plasma concentrations, and the dose needs to be adjusted carefully.

Japanese Chloraniline Carbamate Tablets Medication for Special Populations

Special populations should be treated with extreme caution. The following content will provide medication recommendations for pregnant women, children, the elderly and other groups.

Pregnant and lactating women

Pregnant women or those who may become pregnant should weigh the benefits of treatment and potential risks before taking the drug. Breastfeeding women should evaluate whether to suspend medication based on the benefits of breastfeeding and the necessity of treatment.

Children and the elderly

The safety and effectiveness of children's medicines have not been established and their use should be avoided. Due to the decline in physiological functions of the elderly, it is recommended to appropriately reduce the dosage and closely monitor tolerance.

Patients with renal impairment

There are no clear recommendations for dose adjustment. Renal function should be monitored as appropriate during clinical use to avoid adverse reactions caused by drug accumulation.

Medications for special populations require individualized evaluation to minimize potential risks.